(0.05%) 5 471.85 points
(0.17%) 39 180 points
(0.30%) 17 771 points
(0.09%) $80.90
(-5.04%) $2.62
(-0.83%) $2 311.50
(-0.17%) $28.82
(3.22%) $1 018.20
(0.33%) $0.936
(0.75%) $10.68
(0.49%) $0.792
(-0.28%) $87.25
-14.63% $ 1.050
Live Chart Being Loaded With Signals
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods...
Stats | |
---|---|
Dagens volum | 1 734 |
Gjennomsnittsvolum | 0 |
Markedsverdi | 32.46M |
EPS | $-0.0603 ( Q2 | 2024-04-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-26 | Carle Vanessa | Buy | 12 500 | Stock Options |
2023-10-26 | Docherty John Martin | Buy | 30 000 | Stock Options |
2023-10-26 | Bunka Christopher | Buy | 30 000 | Stock Options |
2023-07-25 | Baxter Nicholas W | Buy | 5 000 | Stock Options |
2023-07-25 | Mckechnie William Edward | Buy | 5 000 | Stock Options |
INSIDER POWER |
---|
95.95 |
Last 99 transactions |
Buy: 5 639 011 | Sell: 3 601 735 |
Lexaria Bioscience Corp. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Lexaria Bioscience Corp. Økonomi
Annual | 2023 |
Omsetning: | $226 208 |
Bruttogevinst: | $194 708 (86.07 %) |
EPS: | $-1.010 |
FY | 2023 |
Omsetning: | $226 208 |
Bruttogevinst: | $194 708 (86.07 %) |
EPS: | $-1.010 |
FY | 2022 |
Omsetning: | $255 397 |
Bruttogevinst: | $183 556 (71.87 %) |
EPS: | $-1.240 |
FY | 2021 |
Omsetning: | $722 738 |
Bruttogevinst: | $547 392 (75.74 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company\'s DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.